Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

Trading Update

28 Jan 2009 07:00

Embargoed Release: 07:00hrs Wednesday 28 January 2008

SOPHEON PLC ("Sopheon" or the "Group") TRADING UPDATE

Sopheon plc, the international provider of software and services that improve the financial return from innovation and product development investments, announces significant progress in year-on-year operating performance. Total revenues for the year ended 31 December 2008 are expected to exceed £9 million compared to £6.3 million in 2007. The year-end close process is not complete, but initial indications are that the Group's EBITDA result will be in line with analyst expectations of £900,000. The EBITDA result in 2007 was £113,000.

License fees comprised a higher percentage of the revenue mix in 2008 than in the prior year. Approximately 65% of revenues in 2008 were derived from existing customers, demonstrating their commitment to Sopheon solutions and underpinning the revenue potential for the coming year. We entered 2009 with a base of recurring revenue - comprising annual maintenance, hosting and rental license contracts - that exceeded £3.6 million. Adding ongoing services projects contracted in 2008 to this recurring base, takes full-year revenue visibility* for 2009 to over £4 million. Looking ahead, the sales pipeline remains resilient, in spite of the economic turmoil. The Group has designed its software to help companies that need to exercise cost control in the short-term, while driving forward innovation to meet their long-term strategic goals. In the current climate, this is a strong selling point for Sopheon's solution. Nevertheless, the Group has adopted a prudent stance in its cost management, and will continue to do so in these uncertain times.

As at 31 December 2008, the Group had gross cash balances of over £2.5 million.

Financial expectations noted above are subject to the completion of the year-end financial close and audit processes. Sopheon plans to issue its preliminary results for the year ended 31 December 2008 on 26 March 2009.

* A definition of how visibility is calculated was provided in our announcement of 25 June 2008.

Barry Mence, Chairman, commented:

"We are very pleased to show such material progress in 2008. Market turbulence makes it hard to predict business development in 2009. We are however very encouraged by the apparent match between our software and the needs of major corporations looking to achieve cost containment while continuing to invest in innovation to ensure their future. Our solutions are ideally placed to support such companies in their efforts to achieve this objective. "

For further information contact:

Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 207 245 1100 Arif Karimjee, CFO Vikki Krause Hansard Communications Tel : + 44 (0) 207 7515 922906 Paul Davies Seymour Pierce Corporate Tel: +44 (0) 20 7107 8000 Finance Claire Verhagen Citigate First Financial Tel : + 31 (0) 205 754 010About Sopheon

Sopheon is an international provider of software and services that help organisations improve the business impact of product innovation. Sopheon's Accolade® solution automates the product innovation process and provides decision support for the management of product portfolios. Its Vision Strategistâ„¢ offering automates the strategic product roadmapping process, allowing users to visualise and forecast the future of products, markets and technologies. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

vendor
Date   Source Headline
11th Apr 20167:00 amRNSDirectors Options and Shareholding
21st Mar 20167:00 amRNSAmendment to Terms of Convertible Loan Stock
17th Mar 20167:00 amRNSFinal Results
21st Jan 20168:29 amRNSAccolade Release 10.2
8th Jan 20167:00 amRNSTrading Update and Board Change
20th Oct 20159:33 amRNSDirector Dealing
19th Oct 20157:00 amRNSDirector Dealing
9th Oct 20153:41 pmRNSDirector Dealing
9th Oct 20151:12 pmRNSDirector Dealing
2nd Oct 20153:39 pmRNSDirector Dealing
23rd Sep 20157:00 amRNSAccolade Release 10.1
27th Aug 20157:01 amRNSHalf Yearly Report
1st Jul 20157:00 amRNSDirector Shareholding
10th Jun 20151:44 pmRNSResult of AGM
10th Jun 20157:00 amRNSAGM Statement
2nd Jun 20157:00 amRNSAccolade 10.0 release
15th May 20153:10 pmRNSNotice of AGM
7th May 201511:40 amRNSDIRECTOR SHAREHOLDING
23rd Apr 201511:10 amRNSDirector Shareholding
20th Apr 201511:43 amRNSDirector Shareholding
13th Apr 20152:03 pmRNSHolding(s) in Company
10th Apr 201511:05 amRNSHolding(s) in Company
8th Apr 20157:00 amRNSDELISTING FROM ALTERNEXT AMSTERDAM
19th Mar 20157:00 amRNSFinal Results
20th Feb 20157:00 amRNSSopheon Releases Accolade® 9.3
5th Feb 20154:12 pmRNSChange of Registered Office
28th Jan 20157:00 amRNSTrading Update
19th Dec 201410:30 amRNSResult of General Meeting
12th Dec 20143:00 pmRNSTrading Update
2nd Dec 20144:00 pmRNSProposed Share Subdivision
2nd Dec 20147:00 amRNSDirector/PDMR Shareholding
27th Oct 20144:15 pmRNSDirector/PDMR Shareholding
22nd Oct 20143:45 pmRNSDirector/PDMR Shareholding
21st Oct 20147:00 amRNSDirector/PDMR Shareholding
17th Oct 20141:50 pmRNSDirector/PDMR Shareholding
10th Oct 201411:15 amRNSResult of GM and Further re Share Consolidation
24th Sep 20147:00 amRNSAccolade 9.2 Release
12th Sep 20147:00 amRNSShare Consolidation
28th Aug 20147:00 amRNSHalf Yearly Report
11th Jun 201412:20 pmRNSResult of AGM
11th Jun 20147:00 amRNSAGM Statement
2nd Jun 20147:00 amRNSAmendment To The Terms Of Convertible Loan Stock
22nd May 20147:00 amRNSAlternext Amsterdam
1st May 20147:00 amRNSInterim Management Statement
22nd Apr 20147:01 amRNSSopheon Delivers Accolade Release 9.1
11th Apr 20147:00 amRNSWind Down Of Alternext Amsterdam
20th Mar 20147:01 amRNSTotal Voting Rights
20th Mar 20147:00 amRNSPreliminary Results
6th Mar 20147:00 amRNSNew Debt Facility
29th Jan 20148:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.